3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
6
Thoracic
2
Sarcoma
1
Other
1
Head & Neck
1
Breast
1
Conditions
Breast Neoplasms
577
Triple Negative Breast Neoplasms
125
Neoplasm Metastasis
50
Breast Neoplasms, Male
28
Ovarian Neoplasms
26
Neoplasms
26
Inflammatory Breast Neoplasms
22
Carcinoma, Non-Small-Cell Lung
19
Stomach Neoplasms
14
Endometrial Neoplasms
11
Carcinoma, Ductal, Breast
11
Carcinoma, Ovarian Epithelial
10
Pancreatic Neoplasms
9
Colorectal Neoplasms
9
Melanoma
8
Lung Neoplasms
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
HER2-positive Breast Cancer
7
Squamous Cell Carcinoma of Head and Neck
6
Prostatic Neoplasms
6
Esophageal Neoplasms
6
Carcinoma, Renal Cell
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
4
Brain Neoplasms
4
Anatomic Stage I Breast Cancer AJCC v8
4
Advanced Breast Cancer
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Interventions
eribulin
1
Trastuzumab
1
Paclitaxel
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Ginkgo Extract
1
Fluorodeoxyglucose F18
1
Exercise Therapy
1
Doxorubicin
1
Docetaxel
1
Cycloserine
1
Cyclophosphamide
1
Carnitine
1
Carboplatin
1
Aromatase Inhibitors
1
Amifostine
1
Acupuncture Therapy
1
2,2'-dithiodiethanesulfonic acid
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurotoxicity Syndromes
×
Paclitaxel
×
Breast
×
Clear all
NCT01763710
2016-03-29
neurabrax
Fundacion Oncosur
Phase 2
Completed
60 enrolled